ELUTIA INC.
Develops drug-eluting biologics to reduce complications from medical implants.
ELUT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US05479K1060
- LEI:
- Country:
- United States of America
- Address:
- 12510 PROSPERITY DRIVE, 20904 SILVER SPRING
- Website:
- https://elutia.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Elutia Inc. is a commercial-stage company that develops and commercializes drug-eluting biologic products to improve compatibility between medical devices and patients. The company's proprietary drug-eluting biomaterial platforms combine natural biologic materials with extended-release antibiotics to address post-surgical complications from implant failures. Its key offerings include CanGaroo, an acellular device envelope for implantable electronics like pacemakers and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. These products are designed to mitigate fibrotic responses, ensure implant stability, and support wound healing. Formerly known as Aziyo Biologics, the company rebranded to Elutia to reflect its strategic focus on drug-eluting biomatrices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ELUTIA INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ELUTIA INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ELUTIA INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
